Early Training of Attention After Acquired Brain Injury
Launched by KAROLINSKA INSTITUTET · Mar 17, 2014
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
STUDY METHODS The primary objectives of the study were: 1. In the acute stage, to evaluate the effectiveness of APT measured by the changes in performance in the attention measure, Paced Auditory Serial Addition Test, (PASAT) evaluated by Statistical Process Control 2. In the postacute stage, to evaluate and compare effects of Attention process training (APT) vs. standard rehabilitation on daily activities and return to work three months and one year after participating in a rehabilitation programme with regard to resource utilisation and health economics.
STUDY DESIGN AND SETTING The stud...
Gender
ALL
Eligibility criteria
- • Inclusion
- • mild to moderate stroke
- • traumatic brain-injury
- • deficits in attention defined by the APT test
- • lower average and above for reasoning skills
- • lower average and above for abstract thinking
- • good understanding of the Swedish language
- • Exclusion
- • moderate to severe aphasia
- • ongoing psychiatric illness
- • history of severe somatic disorder causing anoxic periods
- • ongoing substance abuse
- • severe pain severe memory disorders,
- • neglect
- • visual field defects
- • motor disability interfering with participation
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Patients applied
Trial Officials
Aniko Bartfai, PhD
Principal Investigator
Karolinska institutet, KIDS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials